RESOURCES
Items 145-151 of 151 Results
-
From clumps to consistency: Advancing reproducible 3D cancer models
Reliable 3D cancer models are essential – but conventional tumorsphere workflows can still produce inconsistent, heterogeneous clumps. In this webinar, we'll introduce a streamlined, matrix free workflow built around our 3D Tumorsphere Medium XF. This approach enables the generation of uniform, robust tumorspheres across multiple cancer types – without additional tools or extracellular matrices. We'll share data showing improved tumorsphere formation efficiency and long term expansion of patient derived tumor cells while preserving key tumor characteristics. We’ll then explore how these robust spheroids can be integrated into the MIVO® cancer-on-chip platform, from React4Life, to move from static cultures to dynamic, physiologically relevant systems. By recreating key biophysical cues of the tumor microenvironment, this approach supports more predictive studies of tumor behavior and drug response. What you'll learn: How to generate uniform, reproducible tumorspheres using a matrix free workflow Strategies to support cancer stem cell–driven growth across cancer types How to integrate 3D spheroids into dynamic cancer on chip systems How fluid flow and shear stress improve modeling of tumor invasion and drug efficacy -
Murine and rat cells compatible with PromoCell media
A curated list of publications featuring the use of our cell culture media in murine and rat systems, extracted from our 'Other species and cell types' brochures. -
Enhance experimental consistency with serum-free media
Discover the key advantages of our serum-free media. -
Modeling tumor-immune interactions for immune cell therapy development
Explore six key considerations that can help you design preclinical models that better reflect tumor-immune interactions and support more interpretable immune cell therapy research. -
Why model design matters for cell therapy development
Learn how thoughtful preclinical model design can help you better capture tumor-immune interactions and generate more interpretable data for immune cell therapy development. -
Need ACF media for your path to GMP applications?
From discovery and translational research to GMP manufacturing, we help you identify, optimize, evaluate, and scale animal component-free (ACF) cell culture media solutions tailored to your application. -
PDOs or ex vivo tumor tissue cultures? Choosing the right preclinical model
Which model best fits your translational research - patient-derived organoids or ex vivo tumor tissue cultures?See how each approach compares on tumor microenvironment preservation, scalability, reproducibility, and study duration. Download the on-demand webinar for practical guidance on choosing and establishing the right model for your workflow. Discover how our cancer culture solutions can support both PDO and tumor tissue culture research. Key takeaways from the webinar: How PDOs and tumor slice cultures differ in tumor microenvironment preservation, scalability, reproducibility, and experimental timescale Where each model offers advantages for drug screening, immunotherapy research, and other translational applications Key practical considerations when establishing and maintaining PDO and tumor tissue culture workflows How tumor slice cultures and PDOs can be used as complementary models to generate insights from the same patient material